Skip to main content
SpringerLink
Log in

Prévention des récidives d’accident vasculaire cérébral

  • Chapter
Accident vasculaire cérébral et médecine physique et de réadaptation: Actualités en 2010

  • 750 Accesses

Résumé

Les accidents vasculaires cérébraux (AVC) sont la première cause de mortalité avec les maladies cardio-vasculaires en général, dans les pays industrialisés, ainsi que la première cause de handicap acquis de l’adulte. On estime globalement qu’il y a 2 400 nouveaux AVC par million d’habitants chaque année (1), dont moins de la moitié récupère de façon complète leur indépendance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Truelsen T, Piechrowski B, Bonita R et al. (2006) Stroke incidence and prevalence in Europe. Europ J Neurol 13: 581–598

    Article  CAS  Google Scholar 

  2. Yusuf S, Sleight P, Pogue J et al. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145–153

    Article  CAS  PubMed  Google Scholar 

  3. PROGRESS Collaborative Group (2001) Randomized trial of a perindopril based blood-pressure-lowering regimen among 6 105 individuals with previous stroke or transient ischaemic attack. Lancet 358: 1033–1042

    Article  Google Scholar 

  4. Schrader J, Luders S, Kulschewski A et al. (2005) Mortality and morbidity after stroke — Eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 36: 1218–1226

    Article  CAS  PubMed  Google Scholar 

  5. Rashid P, Leonardi-Bee J, Bath P (2003) Blood pressure reduction and secondary prevention of stroke and other vacular events: a systematic review. Stroke 34: 2741–2748

    Article  PubMed  Google Scholar 

  6. Viscoli C, Brass L, Kernan W et al. (2001) A clinical trial of estrogen-replacement therapy after ischaemic stroke. N Engl J Med 345: 1243–1249

    Article  CAS  PubMed  Google Scholar 

  7. MRC/BHF (2002) Heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360: 7–22

    Article  Google Scholar 

  8. Piechowski-JOzwiak B, Bogousslavsky J (2004) Stroke prevention with lipid — lowering therapy. Expert Rev Neurothepeutics 4: 233–239.

    Article  CAS  Google Scholar 

  9. Awarenes P, Bogousslavsky J, Collahan A et al., for the SPARCL investigators (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355: 549–559

    Article  Google Scholar 

  10. Sacco R (2001) Extracranial carotid stenosis. N Engl J Med 345: 1113–1118

    Article  CAS  PubMed  Google Scholar 

  11. ECST Investigators (1991) Interim results for symptomatic patients with severe (70–99 %) or with mild (0–29%) carotid stenosis. Lancet 337: 1235–1243

    Article  Google Scholar 

  12. CAVATAS Investigators (2001) Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Lancet 357: 1729–1737

    Article  Google Scholar 

  13. Gurm HS, Yadav JS, Fayad P et al. (2008) Long-term results of carotid stenting versus endarterectomy in high risk patients: The Sapphire Study. N Engl J Med 358: 1572–1579

    Article  CAS  PubMed  Google Scholar 

  14. Brown MM, Ederle J, Bonati LH et al. Safety results of the International Carotid Stenting Study. Early outcome of patients randomised between carotid stenting and endarterectomy for symptomatic carotid stenosis. European Stroke Conference 2009, May 22: Stockholm, Sweden

    Google Scholar 

  15. Antithrombotic Trialists’ Collaboration (2002) Collaborative meta-anlalysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 324: 71–86

    Article  Google Scholar 

  16. Gorelick P, Richardson D, Kelly M et al. (2003) Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 289: 2947–2957

    Article  CAS  PubMed  Google Scholar 

  17. CAPRIE Committee (1996) A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348: 1329–1339

    Article  Google Scholar 

  18. Diener HC, Bogousslavsky J, Brass LM et al. (2004) MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364: 331–337

    Article  CAS  PubMed  Google Scholar 

  19. Sacco RL, Diener HC, Yusuf S et al. (2008) Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 359: 1238–1251

    Article  CAS  PubMed  Google Scholar 

  20. Bogousslavsky J, Boysen G, Bornstein N, for the EAFT Investigators (1993) Secondary prevention in non-rheumatic atrial fi brillation after TIA or minor stroke. Lancet 342: 1255–1262

    Google Scholar 

  21. WARSS group (2001) A comparaison of warfarn and aspirin for the prevention of recurrent ischemic stroke. NEJM 345: 1444–1451

    Article  Google Scholar 

  22. Dabigatran Investigators (2009) Dabigatran versus Warfarin in patients with atrial fi brillation. NEJM 361: 1450–1458

    Google Scholar 

  23. Toole JF, Malinow MR, Chambless LE et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291: 565–575

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de neurologie, Clinique Valmont-Genolier, Route de Valmont 22, CH-1823, Glion-sur-Montreux

    Julien Bogousslavsky

Authors
  1. Julien Bogousslavsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Bogousslavsky, J. (2010). Prévention des récidives d’accident vasculaire cérébral. In: Accident vasculaire cérébral et médecine physique et de réadaptation: Actualités en 2010. Springer, Paris. https://doi.org/10.1007/978-2-8178-0109-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0109-4_4

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0108-7

  • Online ISBN: 978-2-8178-0109-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation